In some studies, it has been demonstrated that the FCRL1 gene expression levels expression in patients with multiple sclerosis, lupus anticoagulants, arteritis, and von Willebrand disease are higher than that of healthy subjects [21]. This evidence concerns the gene FCRL1 and platelet-type von Willebrand disease.